
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver
Author(s) -
Motoyuki Kohjima,
Tsuyoshi Yoshimoto,
Munechika Enjoji,
Nobuyoshi Fukushima,
Kunitaka Fukuizumi,
Tsukasa Nakamura,
Mamoru Kurokawa,
Nao Fujimori,
Yoshiyuki Sasaki,
Yasushi Shimonaka,
Yusuke Murata,
Susumu Koyama,
Ken Kawabe,
Kazuhiro Haraguchi,
Yorinobu Sumida,
Naohiko Harada,
Masaki Kato,
Kazuhiro Kotoh,
Makoto Nakamuta
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i11.3291
Subject(s) - hepcidin , ferroportin , transferrin receptor , hepatitis c virus , liver biopsy , medicine , transferrin , biology , immunology , virus , anemia , biopsy
To investigate the relationship between the iron-metabolism-related gene expression profiles and efficacy of antiviral therapy in chronic hepatitis C patients.